Your browser is no longer supported. Please, upgrade your browser.
Settings
DSCI Derma Sciences, Inc. daily Stock Chart
DSCI [NASD]
Derma Sciences, Inc.
Index- P/E- EPS (ttm)-0.31 Insider Own1.40% Shs Outstand29.84M Perf Week-2.17%
Market Cap134.28M Forward P/E- EPS next Y-0.11 Insider Trans0.00% Shs Float26.28M Perf Month-1.10%
Income-8.20M PEG- EPS next Q-0.06 Inst Own59.50% Short Float0.47% Perf Quarter-1.96%
Sales88.60M P/S1.52 EPS this Y6.70% Inst Trans-5.12% Short Ratio3.13 Perf Half Y12.50%
Book/sh4.13 P/B1.09 EPS next Y8.30% ROA-2.20% Target Price8.50 Perf Year-0.44%
Cash/sh1.37 P/C3.28 EPS next 5Y- ROE-2.80% 52W Range2.85 - 5.86 Perf YTD-1.53%
Dividend- P/FCF- EPS past 5Y-15.40% ROI-20.00% 52W High-22.29% Beta0.98
Dividend %- Quick Ratio1.00 Sales past 5Y8.40% Gross Margin41.10% 52W Low59.65% ATR0.24
Employees260 Current Ratio1.30 Sales Q/Q22.50% Oper. Margin-14.90% RSI (14)48.81 Volatility4.91% 5.77%
OptionableYes Debt/Eq0.00 EPS Q/Q7.30% Profit Margin-3.30% Rel Volume0.51 Prev Close4.50
ShortableYes LT Debt/Eq0.00 EarningsNov 10 BMO Payout- Avg Volume39.22K Price4.55
Recom2.00 SMA20-0.22% SMA50-1.30% SMA2009.59% Volume10,008 Change1.11%
Jan-08-16Reiterated Oppenheimer Outperform $8 → $7
Dec-03-15Reiterated ROTH Capital Buy $16 → $9.50
Nov-13-15Reiterated Piper Jaffray Neutral $6 → $4
Nov-13-15Reiterated Oppenheimer Outperform $17 → $8
Aug-14-14Reiterated Oppenheimer Outperform $19 → $18
Mar-17-14Reiterated Oppenheimer Outperform $19 → $21
Jul-06-11Initiated Oppenheimer Outperform $21
Feb-09-11Reiterated Rodman & Renshaw Mkt Outperform $13 → $25
May-14-10Initiated Rodman & Renshaw Mkt Outperform $13
Nov-30-16 12:15PM  ETFs with exposure to Derma Sciences, Inc. : November 30, 2016
Nov-28-16 10:48AM  Derma Sciences, Inc. :DSCI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016
Nov-17-16 01:04PM  DERMA SCIENCES, INC. Financials
Nov-14-16 10:00AM  Edited Transcript of DSCI earnings conference call or presentation 10-Nov-16 4:00pm GMT
Nov-10-16 04:00PM  Derma Sciences to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum Business Wire
11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
07:45AM  Derma Sciences reports 3Q loss
07:30AM  Derma Sciences Reports 2016 Third Quarter Financial Results Business Wire
07:07AM  Q3 2016 Derma Sciences Inc Earnings Release - Before Market Open
Nov-09-16 05:24PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Nov-02-16 04:00PM  Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th Business Wire
Oct-21-16 05:23PM  DERMA SCIENCES, INC. Files SEC form 8-K/A, Financial Statements and Exhibits
Oct-05-16 10:16AM  ETFs with exposure to Derma Sciences, Inc. : October 5, 2016
Sep-26-16 09:04AM  Henry Schein (HSIC) Grows Through Acquisitions, Runs Risks
Sep-23-16 08:43AM  Medtronic (MDT): Valiant Captivia Data Positive at Three Years
08:38AM  LabCorp: Strong Fundamentals, Sequenom Buyout Raise Hope
Sep-21-16 02:02PM  Derma Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference Business Wire
Sep-08-16 05:10PM  DERMA SCIENCES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and
Sep-01-16 04:05PM  Derma Sciences Completes the Sale of Its First Aid Products Division Business Wire
Aug-30-16 08:50AM  Others Overlooked Derma Sciences (DSCI), Should You Buy It Now?
Aug-26-16 04:31PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers -5.60%
Aug-25-16 05:26PM  LabCorp's Takeover of Sequenom Wins Antitrust Clearance
07:30AM  Derma Sciences Receives Reimbursement Coding for New MEDIHONEY® Hydrogel Dressings Business Wire
Aug-24-16 04:05PM  Derma Sciences AMNIOEXCEL® Now Eligible for Reimbursement by Medicare Administrative Contractor NGS Business Wire
Aug-18-16 01:52PM  Edited Transcript of DSCI earnings conference call or presentation 9-Aug-16 3:00pm GMT
07:30AM  Derma Sciences Names Russell Olsen President of Advanced Wound Care Business Wire
Aug-17-16 01:10PM  ETFs with exposure to Derma Sciences, Inc. : August 17, 2016
Aug-15-16 01:50PM  Derma Sciences, Inc. :DSCI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
Aug-11-16 05:11PM  DERMA SCIENCES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equ
07:17AM  New Strong Buy Stocks for August 11th
Aug-09-16 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
08:42AM  Derma Sciences posts 2Q profit
07:30AM  Derma Sciences Reports 2016 Second Quarter Financial Results Business Wire
07:07AM  Q2 2016 Derma Sciences Inc Earnings Release - Before Market Open
Aug-08-16 05:26PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Aug-03-16 09:13AM  Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 9th Business Wire +5.44%
Aug-01-16 06:06AM  DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal
Jul-29-16 08:08AM  Term Sheet Friday, July 29 at Fortune
Jul-28-16 07:30AM  Derma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced Wound Care and Regenerative Products Business Wire +12.53%
Jul-27-16 07:30AM  Derma Sciences to Sell First Aid Products Division for Approximately $12.2 Million Business Wire +6.16%
Jul-20-16 12:20PM  ETFs with exposure to Derma Sciences, Inc. : July 20, 2016
Jul-08-16 08:59AM  Becton, Dickinson (BDX) at 52-Week High on New Launches
08:54AM  Halyard Health Now a Strong Buy, Portfolio Key Catalyst
Jul-05-16 09:29AM  CR Bard: Expansion Plans on Track, Product Pipeline Strong
Jun-03-16 04:43PM  DERMA SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-24-16 08:35AM  Why Derma Sciences (DSCI) Could Be Positioned for a Surge
May-23-16 12:29PM  Derma Sciences, Inc. :DSCI-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
May-19-16 08:56AM  Can The Uptrend Continue for Derma Sciences (DSCI)?
May-11-16 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
07:37AM  Derma Sciences reports 1Q loss
07:30AM  Derma Sciences Reports 2016 First Quarter Financial Results Business Wire
May-10-16 05:21PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report +6.38%
May-06-16 02:31PM  Derma Sciences to Hold First Quarter Financial Results Conference Call on May 11th Business Wire
Apr-27-16 07:30AM  Derma Sciences Announces AMNIOEXCEL® Is Now Eligible for Reimbursement by Medicare Administrative Contractor CGS Business Wire
Apr-04-16 01:59PM  Edited Transcript of DSCI earnings conference call or presentation 16-Mar-16 3:00pm GMT
Mar-16-16 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today
08:30AM  Medical Products Companies Tap Into $50 Billion U.S. Government GSA Supply Program Accesswire
07:49AM  Derma Sciences reports 4Q loss
07:30AM  Derma Sciences Reports 2015 Fourth Quarter and Full Year Financial Results Business Wire
07:07AM  Q4 2015 Derma Sciences Inc Earnings Release - Before Market Open
Mar-15-16 05:18PM  DERMA SCIENCES, INC. Files SEC form 10-K, Annual Report
Mar-10-16 09:52AM  Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 16th Business Wire
Mar-07-16 07:30AM  Findings from Multicenter Study Comparing Derma Sciences AMNIOEXCEL® Against Standard-of-Care for Treating Diabetic Foot Ulcers Published in WOUNDS, a Leading Peer-Reviewed Journal Business Wire +7.52%
Mar-03-16 09:50AM  STAAR Surgical Posts Break-Even Q4 Earnings, Sales Rise
08:30AM  Derma Sciences AMNIOEXCEL® Now Eligible for Reimbursement by Medicare Administrative Contractor WPS Business Wire
Mar-01-16 06:16AM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-25-16 11:18AM  Patterson Companies Beats Q3 Earnings on Robust Sales
Feb-03-16 10:40AM  Becton, Dickinson Beats Q1 Earnings, FY16 View Raised
Jan-20-16 08:00AM  BioLargo Closes Financing To Advance Its Novel Wound Care Products Accesswire
Jan-07-16 07:30AM  Derma Sciences Provides 2015 Preliminary Net Sales and Introduces 2016 Financial Guidance -13.89%
Dec-22-15 09:51AM  Derma Sciences, Inc. Earnings Analysis: Q3, 2015 By the Numbers
08:36AM  Is Derma Sciences (DSCI) Stock a Solid Choice Right Now?
Dec-21-15 05:14PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:30AM  Derma Sciences Announces Leadership and CEO Transition Business Wire
Dec-16-15 11:10AM  Starboard Trims Office Depot Stake Amid FTC Challenging Merger with Staples; Broadfin Capital Buys More Derma Sciences Inc. (DSCI) at Insider Monkey
Dec-01-15 06:01PM  Is Independence Contract Drilling Inc (ICD) A Good Stock To Buy? at Insider Monkey
Nov-30-15 12:59PM  Is Derma Sciences Inc (DSCI) a Good Buy? at Insider Monkey
Nov-26-15 07:32AM  Fortress Biotech Inc (FBIO)Hedge Funds Are Snapping Up at Insider Monkey
Nov-24-15 04:00PM  Derma Sciences to Participate in the 27th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-20-15 08:37AM  How Derma Sciences (DSCI) Stock Stands Out in a Strong Industry
Nov-16-15 07:30AM  Derma Sciences to Participate in the Canaccord Genuity 2015 Medical Technology & Diagnostics Forum Business Wire
Nov-12-15 12:33PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud by Derma Sciences, Inc. and Certain Officers and Directors Business Wire -27.86%
11:05AM  Why Are These Five Stocks Plunging on Thursday? at Insider Monkey
10:45AM  Derma Sciences (DSCI) Stock Falls After Ending Drug Trial at TheStreet
08:30AM  Derma Sciences Inc Business Update Call scheduled for 8:30 am ET today
07:48AM  Derma Sciences to stop developing foot-ulcer drug
07:30AM  Derma Sciences Announces Results of Futility Analyses for Phase 3 Clinical Trials of Aclerastide in Diabetic Foot Ulcer Healing Business Wire
Nov-11-15 04:05PM  Derma Sciences to Hold Conference Call on November 12 to Discuss Data Monitoring Committee Pre-Specified Interim Analysis of the Aclerastide Phase 3 Trials Business Wire
Nov-09-15 10:00AM  Derma Sciences Inc Earnings Call scheduled for 10:00 am ET today +10.76%
07:45AM  Derma Sciences reports 3Q loss
07:30AM  Derma Sciences Reports Third Quarter 2015 Financial Results Business Wire
07:07AM  Q3 2015 Derma Sciences Inc Earnings Release - Before Market Open
Nov-06-15 05:46PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Nov-03-15 08:30AM  Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 9th Business Wire
Oct-06-15 02:58PM  Roth Capital Reiterates Buy on Three Pharma Stocks at Investopedia
Oct-05-15 02:38PM  Three Pharma Picks That Could Double or Triple at Barrons.com
Oct-02-15 10:50AM  Derma Sciences, Inc. Earnings Q2, 2015
Sep-21-15 02:37PM  ETFs with exposure to Derma Sciences, Inc. : September 21, 2015
10:50AM  Derma Sciences, Inc. breached its 50 day moving average in a Bullish Manner : September 21, 2015
Sep-02-15 01:30PM  Three Stocks That Could Double Your Investment
Derma Sciences, Inc. operates as a medical device company in the wound care market. Its Advanced Wound Care segment offers MEDIHONEY dressings for managing non-chronic and hard-to-heal wounds, including chronic ulcers, burns, and post-operative wounds; TCC-EZ system for patients with diabetic foot ulcers; AMNIOEXCEL for tissue repair, reconstruction, and replacement; and AMNIOMATRIX that is used as a wound covering in the treatment of localized tissue defects. This segment also provides XTRASORB dressings, which convert fluid within the dressings to a gel and lock the exudates into the dressings; BIOGUARD dressings for prophylactic use in the prevention of hospital or community acquired infections through wound sites; ALGICELL AG antimicrobial dressings; and occlusive dressings, such as hydrocolloids, foams, hydrogels, alginates, additional silver antimicrobial dressings, cleansers, and DERMAGRAN products. The company's Traditional Wound Care segment offers gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages, and other compression devices; adhesive bandages and related first aid products; private-label wound care products; wound closure strips, nasal tube fasteners, and catheter fasteners; and general purpose and specialized skin care products. Derma Sciences, Inc. markets its products to acute care, extended care, home health care, nursing homes, hospitals, wound and burn care clinics and physician offices through direct sales force, independent distributors, and manufacturers' representatives. The company was founded in 1984 and is headquartered in Princeton, New Jersey.